SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 75 filers reported holding SESEN BIO INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 4,136 | -45.7% | 0.00% | – |
| Q3 2022 | $3,000 | -70.0% | 7,614 | -35.4% | 0.00% | – |
| Q2 2022 | $10,000 | -9.1% | 11,784 | -34.7% | 0.00% | – |
| Q1 2022 | $11,000 | 0.0% | 18,050 | +36.6% | 0.00% | – |
| Q4 2021 | $11,000 | +10.0% | 13,211 | +2.8% | 0.00% | – |
| Q3 2021 | $10,000 | -65.5% | 12,850 | +105.2% | 0.00% | -100.0% |
| Q2 2021 | $29,000 | -62.8% | 6,261 | -79.0% | 0.00% | 0.0% |
| Q1 2021 | $78,000 | +387.5% | 29,882 | +152.9% | 0.00% | – |
| Q4 2020 | $16,000 | -48.4% | 11,817 | -45.8% | 0.00% | – |
| Q3 2020 | $31,000 | +14.8% | 21,795 | -42.0% | 0.00% | -100.0% |
| Q2 2020 | $27,000 | +440.0% | 37,591 | +328.5% | 0.00% | – |
| Q1 2020 | $5,000 | +66.7% | 8,773 | +173.6% | 0.00% | – |
| Q4 2019 | $3,000 | -25.0% | 3,206 | -7.4% | 0.00% | – |
| Q3 2019 | $4,000 | -42.9% | 3,464 | -14.4% | 0.00% | – |
| Q2 2019 | $7,000 | – | 4,045 | +1409.3% | 0.00% | – |
| Q4 2018 | $0 | – | 268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,711,672 | $2,311,000 | 0.25% |
| Eversept Partners, LP | 1,559,824 | $2,105,762 | 0.25% |
| Virtu Financial LLC | 270,004 | $365,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 147,452 | $199,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 838,500 | $1,132,000 | 0.02% |
| MIRABELLA FINANCIAL SERVICES LLP | 88,350 | $119,000 | 0.02% |
| Stratos Wealth Partners, LTD. | 263,300 | $355,000 | 0.01% |
| AJ WEALTH STRATEGIES, LLC | 79,365 | $107,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 349,176 | $471,000 | 0.01% |
| Qube Research & Technologies Ltd | 330,303 | $446,000 | 0.01% |